TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget April 25, 1997
TCL Archive Women’s Health Trial Not Dead; Pls Say They’ll Improve Protocol, Make New Plans For Full Implementation January 29, 1988
TCL Archive “Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer October 10, 1975
